Evaluation on the effectiveness of the national childhood immunisation programme in Singapore, 1982-2007

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 7, 2010, Pages 532-541

  Liew, Fereen ^a   Ang, Li Wei ^a   Cutter, Jeffery ^a   James, Lyn ^a   Goh, Kee Tai ^a  

^a MINISTRY OF HEALTH   (Singapore)

Author keywords

Epidemiology; Herd immunity; Vaccine preventable diseases

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; CONGENITAL RUBELLA SYNDROME; DIPHTHERIA; EPIDEMIOLOGICAL DATA; HEALTH CARE QUALITY; HEPATITIS B; HERD IMMUNITY; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; NEWBORN; NEWBORN TETANUS; PERTUSSIS; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; RUBELLA; SEROLOGY; SINGAPORE; TETANUS; THERAPEUTIC ABORTION; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS;

EID: 77956068710     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Goh KT. The national childhood immunisation programmes in Singapore. Singapore Med J 1985;26:225-42.
2. Goh KT, Doraisingham S, Tan KL, Oon CJ, Ho ML, Chen AJ, et al. The hepatitis B immunisation programme in Singapore. Bull World Health Organ 1989;67:65-70.
3. Committee on Epidemic Diseases. Introduction of measles-mumps-rubella (MMR) vaccine into the national childhood immunisation programme. Epidemiol News Bull 1989;15:66-8.
4. Committee on Epidemic Diseases. Progress in the elimination of measles from Singapore. Epidemiol News Bull 2003;29:1-5.
5. Ang LW. Seroprevalence of hepatitis B virus infection in adults in Singapore. Epidemiol News Bull 2009;35:10-4.
6. Committee on Epidemic Diseases. BCG revaccination. Epidemiol News Bull 2001;27:74.
7. Ministry of Health. A Guide on Infectious Diseases of Public Health Importance in Singapore. 2nd ed, 1979; 3rd ed, 1983; 4th ed, 1986; 5th ed, 1990; 6th ed, 2004.
8. Goh KT, Yamazaki S. Antitoxic immunity of the population against diphtheria in Singapore. Trop Geogr Med 1987;39:177-81.
9. Committee on Epidemic Diseases. Seroimmunity of the population against diphtheria in Singapore. Epidemiol News Bull 1994;20:43-4.
10. Committee on Epidemic Diseases. Prevalence of pertussis antibody in children and adults in Singapore. Epidemiol News Bull 1995;21:65-6.
11. Committee on Epidemic Diseases. Immune status of the population to poliovirus, diphtheria and tetanus. Epidemiol News Bull 1986;12:11-3.
12. Committee on Epidemic Diseases. Immunity of the Singapore population to tetanus. Epidemiol News Bull 1995;21:19-21.
13. Committee on Epidemic Diseases. Seroepidemiology of measles, mumps and rubella. Epidemio News Bull 1991;17:25-6.
14. James L, Fong CW, Foong BH, Wee MK, Chow A, Shum E, et al. Hepatitis B seroprevalence study 1999. Sinapore Med J 2001;42:420-4.
15. Ang LW, Chua LT, James L, Goh KT. Epidemiological surveillance and control of rubella in Singapore, 1991-2007. Ann Acad Med Singapore 2010;39:95-101.
16. Yew YW, Ye T, Ang LW, Ng LC, Yap G, James L, et al. Seroepidemiology of dengue virus infection in adults in Singapore. Ann Acad Med Singapore 2009;38:667-75.
17. Committee on Epidemic Diseases. Changing epidemiology of measles in Singapore. Epidemiol News Bull 1997;23:31-3.
18. Goh KT. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain. Lancet 1999;354:1355-6.
19. Goh KT, Yamazaki S. Immune status of the population to poliovirus infection in Singapore. Bull World Health Org 1987;65:83-6.
20. Committee on Epidemic Diseases. Prevalence of neutralising antibody against poliovirus 1, 2 and 3 in Singapore. Epidemio News Bull 1994;20:63-5.
21. Committee on Epidemic Diseases. Prevalence of antibodies to measles in Singapore. Epidemiol News Bull 2000;26:10-1.
22. Ong G, Heng BH, Ong A, Chua LT, Chew SK, Goh KT. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004. Southeast Asian J Trop Med Public Health 2006;37:96-101.
23. Committee on Epidemic Diseases. Surveillance of mumps in Singapore, 1998. Epidemiol News Bull 1999;25:27-9.
24. Committee on Epidemic Diseases. Prevalence of antibodies to measles, mumps and rubella in Singapore. Epidemiol News Bull 1995;21:25-9.
25. Committee on Epidemic Diseases. Serosurveillance of rubella in Singapore. Epidemiol News Bull 2001;27:1-3.
26. Goh KT. Epidemiology and control of hepatitis B virus infection in Singapore. Southeast Asian Medical Information Center, Tokyo, 1992.
27. Committee on Epidemic Diseases. Seroepidemiology of hepatitis B virus infection in Singapore. Epidemiol News Bull 1995;21:35-7.
28. Committee on Epidemic Diseases. Serological survey on hepatitis B virus infection in school children in Singapore. Epidemiol News Bull 1996;22:57-9.
29. Committee on Epidemic Diseases. Prevalence of hepatitis B virus markers in Singapore. Epidemiol News Bull 2000;26:1-2.
30. Committee on Epidemic Diseases. Poliomyelitis eradication in Singapore. Epidemiol News Bull 2000;26:65-7.
31. Centers for Disease Control and Prevention. Pertussis. In Atkinson W, Hamborsky J, Wolfe C, editors. Epidemiology and Prevention of Vaccine-preventable Diseases. 8th ed. Washington DC: Public Health Foundation, 2005.
32. Duclos P, Paulsen E. Measles elimination in Canada. Can J Public Health 1995;86: 370.
33. Duclos P, Redd CS, Varughese P, Hersh BS. Measles in adults in Canada and United States: implications for measles elimination and eradication. Int J Epidemiol 1999;28:141-6.
34. Chuang SK, Lau YL, Lim WL, Chow CB, Tsang T, Tse LY. Mass measles immunisation campaign: experience in the Hong Kong Special Administrative Region of China. Bull World Health Organ 2002;80:858-91.
35. Ong G, Goh KT, Ma S, Chew SK. Comparative effi cacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect 2005;51:294-8.
36. Nardone A, Tischer A, Andrews N, Backhouse J, Theeten H, Gatcheva N, et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 2008;86:118-25.
37. Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 1997;26:671-81.
38. Friederichs V, Cameron JC, Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987-2004. Arch Dis Child 2006;91:465-8.
39. Health Protection Agency. Increase in measles cases in 2006, in England and Wales. CDR Wkly 2006;16:3.
40. Burgess DC, Burgess MA, Leask J. The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication? Vaccine 2006;24:3921-8.
41. Heng BH, Goh KT, Chan R, Chew SK, Doraisingham S, Quek GH. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city sate with intermediate HBV endemicity. J Epidemiol Community Health 1995;49:309-13.
42. Centers for Disease Control and Prevention. Recommended adult immunisation schedule-United States. MMWR Morb Mortal Wkly Rep 2007:56:1-4.
43. Annelise Wilder-Smith, Ng S, Earnest A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore 2006;35:780-2.
44. Chan SH, Tan PT, Han HH, Bock HL. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Singapore Med J 2006;47:286-90.
45. Ackerman LK. Update on immunisations in children and adolescents. Am Fam Physician 2008;77:1561-8.
46. Freed GL. Vaccine policies across the pond: Looking at the UK and US systems. Health Aff 2005;24:755-7.
47. Andreae MC, Freed GL, Katz SL. Safety concerns regarding combination vaccines: The experience in Japan. Vaccine 2004;22:3911-6.
48. WHO. Global use of rotavirus vaccines recommended. Available at: http//www.who.int/mediacentre/news/releases/2009/rotavirus_ vaccines_20090605/en/index.html. Accessed 5 June 2009.